Summary and general discussion
The objective of this thesis was to study factors influencing corneal graft survival. These factors can be classified as non-immunological or immunological.
The main non-immunological factor which has increased graft survival since 1939 is the improvement in surgical techniques following the introduction of the operation microscope. A linear relation between the improved surgical skill and the number of less favourable cases which could be operated was observed in many corneal transplantation centers. Patients with highly vascularized corneas and previous corneal graft failures were no longer excluded from corneal transplantation. At the present time, corneal graft rejection due to immunological factors is the ultimate determinant of corneal graft survival.
Of the immunological factors which may influence corneal graft survival, we have studied the effect of the major histocompatibility complex (MHC) and theABO blood group system. The human MHC (HLA) is a genetic system that contains information for polymorphic cell membrane determinants. HLA antigenic incompatibilities provoke strong immunological reactions in tissue transplantation. Furthermore, genes within the HLA-system influence the individual degree of susceptibility to diseases implicating the immune system.
Similar content being viewed by others
References
Alberth B. (1980) Keratoplastik im Säuglings und Kindesalter. Klin. Mbl. Augenheilk. 177: 802–804.
Amos D.B. (1968) Human Histocompatibility locus HL-A. Science 159: 659.
Arentsen J.J., Morgan B. and Green W.R. (1976) Changing indication for keratoplasty. Am. J. Ophth. 81: 313–318.
Batchelor J.R., Casey T.A., Gibbs D.C., Lloyd D.F., Werb A., Prasad S.S. and James A. (1976) HLA matching and corneal grafting. Lancet 1: 551–554.
Benacerraf B. (1981) Role of MHC gene products in immune regulation. Science 212: 1229.
Binkhorst C.D. (1980) Corneal and retinal complications after cataract extraction. Ophthalmol. 87, 7: 609–617.
Bloomfield S.E. (1980) Clinical allergy and immunology of the external eye. In Duane T.D. (ed). Clinical Ophthalmology 5, 28: 20–21.
Bodmer W.F. et al. (1966) Genetics of the ‘4’ and ‘LA’ human leukocyte groups. Ann. N.J. Acad. Sci. 129: 473.
Ceppelini R. et al. (1967) Genetics of leukocyte antigens. A family study of segregation and linkage. In: Histocompatibility Testing 1967, p. 149. Munksgaard, Copenhagen.
Ciba Foundation Symposium (1973) Corneal graft failure, p. 344. Associated Scientific Publishers, Amsterdam/London/New York.
Ciotola G. (1949) Considerazioni sulla cheratoplastica con particolare riguardo agli esiti tardivi. Bull. d'ocul. 28: 471–489.
Dausset J. (1954) Leuko-agglutinins. IV. Leuko-agglutinins and blood transfusion. Vox Sang. 4: 190.
Dausset J., Ivanyi P. and. Ivanyi D. (1965) Tissue alloantigens in human: Identification of a complex system (HU-1) In: Histocompatibility Testing 1965, p. 51. Munksgaard, Copenhagen.
Dieffenbach J.F. (1831) Beitrage zur Verpflanzungder Hornhaut. Ztschr. f. d. Ophth. 1: 172–176.
Duquesnoy R.J., Marrari M. (1980) MB system. In: P.I. Terasaki, Ed. Histocompatibility Testing. Los Angeles, California. UCLA Tissue Typing Laboratory, 552–555.
Hensen E.J. (1983) An approach to study the genetic control of the antigen-specific immune response in man. Diss. Univ. of Leyden.
Jones B.R. (1973) Ciba Foundation Symposium; Corneal graft failure, p. 1. Associated Scientific Publishers, Amsterdam/London/New York.
Kissmeyer-Nielsen F., Svejgaard A. and Hange M. (1968) Genetics of the Human HL-A transplantation system. Nature 219: 1116.
Klein J., Juretic A., Baxevenis C.N. and Nagy Z.A. (1981) The traditional and a new version of the mouse H-2 complex. Nature 291: 455.
Löhnlein W. (1950) Über Keratoplastik. München med. Wohnsche. 92: 1201–1206.
Mayer D.J., Daar A.S., Casey T.A. and Fabre J.W. (1983). Localization of HLA-A, -B and -C and-DR antigens in the human cornea. Transplantation Proceedings vol. XV, no. 1: 126–129.
Medawar P.B. (1946) Immunity to homologous grafted skin II. The relationship between the antigens of blood and skin. Brit. J. Exp. Path. 27:15.
Miescher P. and Fauconnet M. (1954) Mise en evidence de differents groupes leucocytaires chez l'homme. Schweiz. Med. Wschr. 84: 597.
Nelken D. Histocompatibility antigens of the cornea.(1965) In: Histocompatibility Testing Munksgaard, Copenhagen.
Owens W.C., Frank J.J., Leahy B., Messier P.E., Scheie H.G., Vincent B.R., Wadsworth J.A.C. and Stansbury F.C. (1949) Results of corneal transplantations. Am. J. Ophth. 31: 1394–1399.
Payne R. and Rolfs M.R. (1958) Fetomaternal leukocyte incompatibility. J. Clin. Invest. 37: 1756.
Van Rood J.J., Eernisse J.G. and van Leeuwen A. (1958) Leukocyte antibodies in sera from pregnant women. Nature 181: 1735.
Van Rood J.J. (1962) Leukocyte grouping A method and its application. Thesis, University of Leiden.
Van Rood J.J. et al. (1965) Leukocyte groups, the normal lymphocyte transfer test and homograft sensitivity. In: Histocompatibility Testing 1965, p. 35. Munksgaard, Copenhagen.
Van Rood J.J., van Leeuwen A., Ploem J.S. (1976) Simultaneous detection of two cell population by two-colour fluorescence and application to recognition of B-cell determinants. Nature 262, 5571: 795.
Van Rood J.J. (1979) Microlymphocytotoxicity method. In: NIAID Manual of tissue typing techniques. (Ed.: J. Ray) National Institute of Health (NIH) (80-545) Maryland, U.S.A., p. 104.
Roberts J.E. (1950) Statistics on results of keratoplasty. Am. J. Ophth. 33: (part 110) 21–23.
Sanfilippo F. (1982) Critical factors in corneal transplantation. SEOPF, 4.
Shaw S., Johnson A.H. and Shearer G.M. (1980) Evidence for a new segregant series of B cell antigens which are encoded in the HLA-D region and stimulate secondary allogeneic proliferative and cytotoxic responses. J. Exp. Med. 152: 565.
Smith R.E., McDonald R.H., Nesburn A.B. and Minckler D.S. (1980) Penetrating keratoplasty. Arch. Ophthalmol. 98: 1226–1229.
Spielman W. (1955) Serologische Grundlagen der Transfusionsstörungen. Bibli. Haemat. 2: 7.
Stansbury F.C. (1949) Corneal transplantations. Arch Ophth. 42: 813–844.
Terasaki P.I. and McClelland J.D. (1964) Microdroplet assay of human serum cytotoxins. Nature 204: 998.
Thomas C.J. (1955) The cornea, p. 1151. Charles C. Thomas Publishers, Springfield, Illinois, U.S.A.
De Vries R.R.P., Meerakhan P., Bernini L.F., van Loghem E., Van Rood J.J. (1979) Genetic control of survival in epidemies. J. Immunogenet 6: 271–287.
Waring G.O., Laibson P.R. (1977) Keratoplasty ininfants and children. Trans. Am. Acad. Ophthalmol. Otolaryngol. 83: 283–289.
References
Breslow N.E. (1979) Statistical methods for censored survival data. Environmental Health Perspectives, 32: 181–192.
Edwards J.U. (1974) HLA and disease. The detection of associations. J. Immunogenet. 1: 249–256.
Gehan E.A. (1969) Estimating survival functions from the life table method. J.Chron.Dis. 21: 629–635.
Gore S.M. (1984) Graft survival after renal transplantation: agenda for analysis. Kidney International. in press.
Kaplan E.L. and Meier P. (1958) Non parametric estimation from incomplete observations. JAMA 53: 457.
Mantel N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50: 163.
Peto J. (1984) The calculation and interpretation of survival curves. Oxford University Press. In press.
Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J. and Smith P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part I, Introduction and design J. Cancer 34: 585–612.
Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J. and Smith P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II, Analysis and examples J. Cancer 35: 1–39.
Sylvester R.J., Mackin D. and Staquet M.J.(1978) A comparison of the alternative methods of calculating survival curves arising from clinical trials. Biomedicine Special Issue 28: 49–53.
Weiner A.S. (1970) Blood groups and disease. Am.J.Hum. Genet. 22: 476–483.
References
Baxt W.G. and Spiegelman S. (1972) Nuclear DNA sequences present in human leukemic cells and absent normal leucocytes. Proc. Nat. Acad. Sci U.S.A. 69: 3737.
Birkmayer G.D., Balda B.R. and Miller F. (1974) Onco-viral information in human melanoma. Europ. J. Cancer 10: 419.
Cassen J.H., Meisler D.M., Zakov Z.M. and Langston R.H.S. (1983) Donor material for corneal grafting. Am.J.Ophthalmol. 95, no. 5: 711–712.
Centraal Bureau v.d. Statistiek (1975) 75 Jaar statistiek in Nederland. Staatsuitgeverij, Den Haag, p. 19.
Collins V.P., Loeffler R.D. and Tivey H. (1956) Observation on growth rates of human tumors. Am.J.Roentgenol. 76: 989.
Einhorn L., Burgers M. and Gottlieb J. (1974) Metastatic patterns of choroidal melanoma. Cancer 34: 1001.
Epstein W.R., Fukuyama K., Benn M., Keston A.S. and Brandt R.B. (1968) Transmission of a pigmented melanoma in golden hamster by a cell-free ultra filtrats. Nature (London) 219: 979.
Filatov V.P. (1934) The cadaver's cornea for corneal transplantation. Sovet Vestnik Oftal. 4: 223.
Hehlman R., Kufe D. and Spiegelman S. (1972) Viral related RNA in Hodgkin's disease and other lymphomas. Proc. Nat. Acad. Sci. U.S.A. 69: 1729.
Jensen O.A. (1982) Malignant melanomas of the human uvea, 25 years follow-up in cases in Denmark, 1943–1952. Acta Ophthalmol. 60: 161.
Manschot W.A. and Peperzeel van H.A. (1980) Choroidal melanoma; enucleation or observation? A new approach. Arch. Ophthalmol. 98: 71.
Spiegelman S., Axel R. and Sehlom J. (1972) Virus related RNA in human and mouse mammary tumors. J.Nat. Cancer Inst. 48: 1205.
Zakov Z.N., Dohlman C.H., Perry H.D. and Albert D.M. (1978) Corneal donor material selection. Am.J.Ophthalmol. 86: 605.
References
Harms, H. and Mackensen, H. (1966) Augenoperationen unter dem Mikroskop. Thieme Verlag, Stuttgart, p 291.
King, J.H. (1972) Eyebank and the availability of corneas in the causes of preventness of blindness. Proc. series, Jerusalem seminar. ed. J.C. Michaelson, E.R. Berman. Academic Press, New York, 273.
Kok-van Alphen, C.C. (1954) Bijdrage tot de keratoplastiek. Diss. Eduard IJdo, Leiden, p 55.
Paufique, M. (1948) Les greffes de la cornée. Masson, Paris, 70.
Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. and Smith, P.G. (1976) Design and analysis of randomized clinical trials recognizing prolonged observation of each patient. J.Br.J. Cancer 34: 585.
Polack, F.M. (1977) Corneal Transplantation. New York, Grune and Stratton, 98–99.
Rood van, J.J. (1979) Microlymphocytotoxicity method. In: NIAID manual of tissue typing techniques (Ed: S. Ray) National Institutes of Health (NIH) (80-545) Maryland, U.S.A.: 104.
De Voe, A.G. (1975) Complications of keratoplasty. The Gifford Lecture. Am.J.Ophthamol. 79: 907–912.
Völker-Dieben, H.J.M., Kok-van Alphen, C.C., Lansbergen, Q. and Persijn, G.G. (1982) Different influences on corneal graft survival in 539 transplants. Acta Ophthalm. 60: 190–202.
Wagoner, M.D., Dohlman, C.H., Albert, D.M., Lavin, P., Murphy, A., O'Neill-Dryja, M. (1981) Corneal donor selection. Ophthalmology vo. 88, 2, 139–144.
References
Batchelor J.R., Casey T.A., Gibbs D.C., Loyd D.F., Werb A., Prasad S.S. and James A. (1976) HLA matching and corneal grafting. Lancet 1: 551–554.
Gibbs D.C., Batchelor J.R., Werb A., Schlesinger W. and Casey T.A. (1974) The influence of tissue typing compatibility on the rate of full-thickness corneal grafts. Trans. Ophthal. Soc. U.K. 94: 101–109.
Grönemeyer U., Pülhorn G. and Müller-Ruchholtz W. (1976) Histoincompatibility and allogeneic corneal grafting between inbred strains of rats. Mod. Probl. Ophthalmol. 16: 161.
Harms H. and Mackensen H. (1966) Augenoperationen unter dem Mikroskop, pp. 291. Thieme Verlag, Stuttgart.
Herold W. (1972) Zum Nachweis der Blutgruppenantigene A und B in der menschlichen Hornhaut mittels der Immunfluoreszenstechnik. Klin. Monatsbl. Augenheilkd. 161: 658.
Khodadoust A.A. (1973) The allograft rejection reaction: The leading cause of late failure of clinical corneal grafts. In: Corneal Graft Failure. Ciba Found. Symp. 15: 151. Associated Scientific Publishers, Amsterdam/London/New York.
Khodadoust A.A. and Abizedeh A. (1979) The fate of corneal grafts after previous rejection reactions. Doc. Ophthalmol. Proc. Ser. 20: 115–122.
Kok-van Alphen C.C. and Völker-Dieben H.J.M. (1980) Impairment of tear production in corneal herpetic diseases. In Herpetische Augenerkrankungen 215–218, J.F. Bergman Verlag, München
Mailäth L., Stenszky V., Alberth B. and Aszödi L. (1972) Die Rolle der Blutgruppen-kompatibilität bei Keratoplastik. Klin. Monatsbl. Augenheilkd. 160: 550–553.
Meyer H.J. (1971) Spielen Blutfaktoren eine Rolle bei der Hornhauttransplantation? Dtsch. Med. Wochenschr. 96: 1259–1260.
Nelkens E., Michaelson J.C., Nelkens D. and Gurevitch J. (1956) ABO antigens in the human cornea. Nature 177: 840.
Persijn G.G., Cohen B., Lansbergen Q. and Van Rood J.J. (1979) Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation 28: 396–401.
Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J. and Smith P. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Br. J. Cancer 34: 585.
Rycroft B.W. (1955) Corneal grafts, pp. 172–173. Butterworth, London.
Van Vreeswijk W. and Balner H. (1980) Major histocompatibility complex matching and other factors influencing skin allograft survival in related and unrelated Rhesus monkeys. Transplantation 30: 196–202.
References
Batchelor J.R., Casey T.A., Gibbs D.C., Lloyd D.F., Werb A., Prasad S.S. and James A. (1976) HLA-A matching and corneal grafting. Lancet 1: 551.
Ciba Foundation Symposium (1973) Corneal Graft Failure, p. 344. Associated Scientific Publishers, Amsterdam/London/New York.
Ehlers N. and Ahrons S. (1971) Corneal transplantation and histocompatibility. Acta Ophthalmol. (Kbh) 49: 513.
Ehlers N. and Kissmeyer-Nielsen F. (1973) Influence of histocompatiblity on the fate of the corneal transplant. In: Corneal Graft Failure, Ciba Foundation Symposium 15: 307. Associated Scientific Publishers, Amsterdam/London/New York.
Ehlers N. and Kissmeyer-Nielsen F. (1979) Corneal transplantation and HLA-compatibility. Acta Ophthalmol. (Kbh) 57: 738–741.
Gibbs D.C., Batchelor J.R., Werb A., Schlesinger W. and Casey T.A. (1974) The influence of tissue-type compatibility on the fate of full-thickness corneal grafts. Trans. Ophthalmol. Soc. UK 94: 101.
Gibbs D.C., Batchelor J.R., Casey T.A., Werb, A. Liakos G. and Taylor C. (1979) HLA- matching and corneal graft rejection. Doc. Ophthalmol. Proc. Ser. 20: 139–149.
Khodadoust A.A. (1973) The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts. In: Corneal Graft Failure. Ciba Foundation Symposium 15: 151. Associated Scientific Publishers, Amsterdam/London/New York.
Khodadoust A.A. and Abizedeh A. (1979) The fate of corneal regrafts after previous rejection reactions. Doc. Ophthalmol. Proc. Ser. 20: 115–122.
Kok-van Alphen C.C. (1954) Bijdrage tot de keratoplastiek. Diss. Eduard Udo, Leiden.
Kok-van Alphen C.C. and Völker-Dieben H.J. (1979) Diagnosis and treatment of complications in the follow-up period after corneal transplantation.
Maumenee A.E. (1951) The influence of donor-recipient sensitization on corneal grafts. Am.J.Ophthalmol. 34: 142.
Paufique M. (1948) Les greffes de la cornée, pp. 134–136. Masson, Paris.
Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N. McPherson K., Peto J. and Smith P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I.Br.J.Cancer 34: 585.
Van Rood J.J. (1979) Microlymphocytotoxicity method. In: NIAID Manual of tissue typing techniques (Ed.: J. Ray) National Institutes of Health (NIH) (80-545) Maryland, U.S.A.: 104.
Stark W.J., Taylor H.R. and Bias W.B. (1979) Keratoplasty and transplantation antigens. Doc. Ophthalmol. Proc. Ser. 20: 123–130.
Vannas S. (1970) Some features of ophthalmology in Finland. Am.J.Ophthalmol. 70: 422–426.
Vannas S., Karjalainen P., Ruusuvaara A. and Tiilikainen A. (1976) HLA-compatible donor for prevention of allograft reaction. Albrecht von Grafes Arch. Klin. Ophthalmol. 198: 217.
Völker-Dieben H.J., Kok-van Alphen C.C., Oosterhuis J.A., van Dorp G. and van Leeuwen A. (1977) First experiences with HLA-matched corneal grafts in high risk cases. Doc. Ophthalmol. 44: 39–48.
Völker-Dieben H.J., Kok-van Alphen C.C., Kruit P.J. (1978) Advances and disappointments, indications and restrictions regarding HLA-matched corneal grafts in high risk cases. Doc. Ophthalmol. 46: 219–22.
References
Braude L.S. and Chandler J.W. (1983) Corneal allograft rejection. The role of the major histocompatibility complex. Surv. of Ophthalmology 27: 290.
Ehlers N. and Ahrons S. (1971) Corneal transplantation and histocompatibility. Acta Ophthalmol. (Kbh) 49: 513.
Jones B.R. (1973) Ciba Foundation Symposium: Corneal graft failure, p. 344. Associated Scientific Publishers, Amsterdam/London/New York.
Lechler R.J. and Batchelor J.R. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J.Exp.Med. vol. 155: 31.
Mayer D.J., Daar A.S., Casey T.A. and Fabre J.W. (1983) Localization of HLA-A, -B, -C and -DR antigens in the human cornea. Transplantation Proceedings, XV, no. 1: 126.
Moen T., Albrechtsen D., Flatmark A., Jakobsen A., Jervell J., Halvorsen S., Solheim B. and Thorsby E. (1980) Importance of HLA-DR matching in cadaveric renal transplantation. N.Eng.J. of Medicine 303, 15: 850.
Paufique M. (1948) Les greffes de la cornée, pp. 134. Masson, Paris.
Persijn G.G., Gabb B.W., Van Leeuwen A., Nachtegaal A, Hoogeboom J., Van Rood J.J. (1978) Matching for HLA antigens of A, B and DR loci in renal transplantation by Eurotransplant. Lancet 1: 1278.
Peto P., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J. and Smith, P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. J.Br.J. Cancer 34: 585.
Rodriques M.M., Rowden G., Hackett J. and Bakos J. (1981) Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol. Vis. Sci. vol. 21., 5: 759.
Van Rood J.J., Van Leeuwen A., Ploem J.S. (1976) Simultaneous detection of two cell population by two-colour fluorescence and application to recognition of B-cell determinants. Nature 262. 5571: 795.
Ting A. and Morris P.J. (1980) Powerful effect of HLA-DR matching on survival of cadaveric renal allografts. Lancet I: 282.
Völker-Dieben H.J., Kok-van Alphen C.C., Lansbergen Q. and Persijn G.G. (1982) The effect of prospective HLA-A and -B matching on corneal graft survival. Acta Ophthalmol. 60: 203.
Völker-Dieben H.J., Kok-van Alphen C.C., D'Amaro J. and de Lange P. (1984) The effect of prospective HLA-A and -B matching in 288 penetrating keratoplasties for herpes simplex keratitis. Acta Ophthalmol. in press.
References
Alberth B. (1980) Keratoplastik im Säuglings- und Kindesalter. Klin. Mbl. Augenheilk. 177: 802.
Batchelor J.R., Casey T.A., Gibbs D.C., Lloyd D.F., Werb A., Prasad S.S. and James A. (1976) HLA-A matching and corneal grafting. Lancet 1: 551–554.
Beauchamp G. R. (1979) Pediatric keratoplasty: problems and management. J. Ped. Ophthalmol. 16: 388.
Brown S.I., Salomon S.M. (1983) Wound healing of grafts in congenitally opaque infant corneas. Am. J. Ophthalmol. 95: 641.
Ehlers N. and Kissmeyer-Nielsen F. (1973) Influence of histo compatibility on the fate of the corneal transplant. In: Corneal graft failure, Ciba Foundation Symposium K: 307. Associated scientific Publishers, Amsterdam/London/New York.
Harms H., Mackensen H. (1966) Augenoperationen unter dem Mikroscop. p. 291. Thieme, Verlag, Stuttgart.
Lemp M.A., Ralph R. (1975) Remarks on pediatric keratoplasty. II World Congress on the Cornea. Washington DC, may 1975.
Peto R., Pike M.C., Armitage P., Breslow N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J., Smith, P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br.J. Cancer 34: 585.
Schwanzlin D.J., Goldberg D.B., Brown S.I. 1980. Transplantation of congenitally opaque corneas. Ophthalmol. 87: 1253.
Vannas S., Karjalainen P., Ruusuvaara A. and Tiilikainen, A. (1976) HLA compatible donor for prevention of allograft reaction. Albrecht von Grafes Arch. Klin. Ophthalmol. 198: 217.
Waring G.O. and Laibson P.R. (1977) Keratoplasty in infants and children. Trans. Am. Acad. Ophthalmol. Otolaryngol. 83: 283. March–April.
References
Arentsen J.J. and Laibson P.R. (1982) Surgical management of pseudophakic corneal edema: complications and visual results following penetrating keratoplasty. Ophthalmic Surgery 13: 371–373.
Binkhorst C.D. (1980) Corneal and retinal complications after cataract extraction. Ophthalmology 87: 609.
Bourne W.M. and Kaufman H.E. (1976) Endothelial damage associated with intraocular lenses. Am.J.Ophthal. 81: 482–485.
Charlton K.H., Binder P.S. and Perl T. (1981) Visual prognosis in pseudophakic corneal transplant. Ophthalmic Surgery 12: 411–419.
Kok-van Alphen C.C. and Völker-Dieben H.J. (1979) Corneal dystrophy following lens implantation. Doc. Ophthalmol. 48 (2): 243–250.
Leonard P. and Rommel J. (1982) Lens implantation, 30 years of progress. Dr. W. Junk Publishers, The Hague, Boston, London.
Maurice D.M. (1968) Cellular membrane activity in the corneal endothelium of the intact eye. Experientia 24: 1094.
Olson R.J., Waltman S.R., Mattingly T.P. and Kaufman H.E. (1979) Visual results after penetrating keratoplasty for aphakic bullous keratopathy and Fuchs' dystrophy. Am.J.Ophthalm. 88: 1000–1004.
Peto R., Pike M.C., Armitage P., Breslow P., Breslow N.E, Cox P.R., Howard S.V, Mantel N., McPherson K., Peto J. and Smith P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Br.J. Cancer 34: 585.
Stanley Muenzler W. and Harms W.K. (1981) Visual prognosis in aphakic bullous keratopathy treated by penetrating keratoplasty: a retrospective study of 73 cases. Ophthalmic Surgery 12: 210–212.
Waltman S.R. (1981) Penetrating keratoplasty for pseudophakic bullous keratopathy. Achr. Ophthalmol. 99: 415–416.
Worst J. (1979) Premier festival du film sur l'implantation du linse. Cannes.
References
Batchelor J.R., Casey T.A, Gibbs D.C., Loyd D.F., Werb A., Prasad S.S. and James A. (1976) HLA matching and corneal grafting. The Lancet 1: 551–554.
Beekhuis W.H., Renardel de Lavalette J.G.C., Van Rij G. and Schaap G.J.P. (1983) Therapeutic keratoplasty for active herpetic corneal disease; viral culture and prognosis. Documenta Ophthalmol. 55: 31–35.
Cobo L.M., Coster D.J., Rice N.S.C., Jones B.R. (1980) Prognosis and management of corneal transplantation for herpetic keratitis. Arch. Ophthalmol. 98: 1755–1759.
Colin J., Goichot E.L. and Petroutsos G. (1981) Complications des kératoplasties sur kératitite herpétiques. J.Fr.Ophthalmol. 4: 12, 829–832.
Draeger J., Koudelka A. and Lubahn E. (1976) Zur Aesthesiometrie der Hornhaut. Klin. med. Augenheilk. 169: 407–421.
Fine N., Cignetti F.E. (1977) Penetrating keratoplasty in herpes simplex keratitis recurrence in grafts. Arch. Ophthalmol. 95: 613–616.
Foster C. (1981) Penetrating keratoplasty for herpes simplex keratitis. In: Sundmacher R., (Hrsg) Herpetic Eye Diseases, Munich, Bergmann, p 425.
Harms H., Mackensen H. (1966) Augenoperationen unter dem Mikroskop. p. 291. Thieme Verlag, Stuttgart.
Kok-van Alphen C.C., Völker-Dieben H.J., Graniewsky-Wijnands H. (1983) Cornea aesthesiometry after perforating keratoplasty. In press.
Peto R., Pike M.C, Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br.J. Cancer 34: 585.
Pfister R.R., Richards J.S.F., Dohlman C.H. (1972) Recurrence of herpetic keratitis in corneal grafts. Am.J.Ophthalmol. 73: 192–196.
Polack F.P., Kaufman H.E. (1972) Penetrating keratoplasty in herpetic keratitis. Am.J.Ophthal. 73: 908–913.
Pouliquen J., Goichot E.L., Petroutsos G. (1981) Complications des kéroplasties sur kératitite herpétiques. J.Fr.Ophthalmol. 4: 12, 829–832.
Rice N.S.C. and Jones B.R. Problems of corneal grafting in herpetic keratitis. (1973) Ciba Foundation Symposium on Corneal Graft Failure. Amsterdam, Associated Scientific Publication, 15: p. 221–239.
Sie S.H. (1980) Recidivprophylaxe mit Trifluorothymidin nach Keratoplastik bei Herpes corneae. Ophthalmologica, Basel 180: 1–8.
Skriver K. (1978) Reinnervation of the corneal graft. Acta Ophthalmologica 56: 1013–1015.
Want v.d. H. (1980) Personal communication.
Witmer R. (1981) Results of keratoplasty in meta herpetic keratitis. In: Sudmacher R., (Hrsg). Herpetic Eye Diseases, Munich, Bergmann, p 419.
References
Edwards J.H. (1974) HLA and disease. The detection of associations. J. Immunogenet. 1: 249.
Haldane J.B.S. (1955) The estimation and signficance of the logarithm of a ratio of frequencies. Ann. Hum. Genet. 20: 30.
Meyers-Elliott R.H. et al. (1980) HLA antigens in herpes stromal keratitis. Am. Ophthalmol. 89: 54–58.
Rood Van J.J. (1979) Microlymphocytotoxicity method. In: NIAID Manual of tissue typing techniques (Ed: J. Ray) National Institute of Health (NIH) (80-545) Maryland, U.S.A.: 104.
Rood Van J.J. (1980) The genetics and biology of the HLA system. In: Benacerraf B., Dorf M.E. (eds) The role of the major histocompatibility complex in immunology. Garland, New York.
Woolf B. (1955) On estimating the relation between blood groups and disease. Ann. Hum. Genet. 19: 251.
Zimmerman T.J. et al. (1977) HLA type and recurrent corneal herpes simplex infection. Invest. Ophthalmol. Visual Sci. 15: 756.
References
Leopold I.H. and Sery T.W. (1963) Epidemiology of herpes simplex keratitis. Invest. Ophthalmol. Visual Sci. 2: 298.
Meyers-Elliott, R.H., Maxwell, W.H. and Petit, T.H. (1981) HLA-DR and susceptibility to Recurrent Herpes Simplex Stromal Keratitis and Progenitalis. In Herpetische Augener-krankungen, J.F. Bergman Verlag, München, p. 81.
Völker-Dieben, H.J.M., D'Amaro, J., De Lange, P. and Wolff-Rouendaal, D. (1983) HLA and ABO antigens in malignant choroidal melanoma. Clin. Exp. Immunol. 53: 581–588.
References
Blagojevic M., Szanojevic-Paovic A., Susakovic N. and Orlic M. 1980. HLA antigens and keratoconus. The Cornea in Health and Disease VI the Congress of European Society of Opthalmol. The Royal Soc. of Medicine and Acc. Press London No. 40: 937–940.
D'Amaro J., Van Rood J.J., Rimm A.A. and Bortin M.M. (1983) HLA associations in Italian and non-Italian Caucasoid aplastic anaemia patients. Tissue Antigens 21: 184–191.
Damgaard-Jensen L., Ehlers N & Kissmeyer Nielsen F. (1979) HLA types in corneal diseases. Acta Ophthal. 57: 982–985.
Edwards J.H. (1974) HLA and disease. The detection of associations. J. of Immunogenet. 1: 249.
Fasset A.R., Richman A.V., Frias J.L. (1977). HLA antigens and keratoconus. Ann. of Ophthalmol. 9: 767–768.
Grayson M. (1979) Degenerations, dystrophies and edema of the cornea. In Duane TD (ed) Clinical Ophthalmology Harper and Row Publishers, Hagerstown, Cambridge 4, 6: 20–21.
Karantinos D., Louletzoglon M., Stavropoulon K., Apostolopoulos M., Renieri N. and Theodossiadis G. Histocompatibility Antigens (HLA) in keratoconus (1980). The Cornea in Health and Disease (VIIth Congress of European Society of Ophthalmol.) The Royal Soc. of Medicine and Ac. Press. London 40: 933–936.
Klouda P.T., Syrbopoulos E.K., Entwhistle C.C., Coffin R.B., Easty P.L. and Brandley B.A. (1983) HLA and keratoconus. Tissue Antigens 21: 397–399.
Nijenhuis L.E. (1961) Blood group frequencies in The Netherlands, Curacao, Suriname and New Guinea. A study in population genetics. Thesis, University Amsterdam.
Vannas S., Vannas A. and Tiilikainen A. (1977). Corneal transplantation reaction in avascular keratoconus patients due to HLA-associated immune aberation against infection. Invest. Ophthalmol. Visual Sci. 644–646.
Völker-Dieben H.J., D'Amaro J., de Lange P. and Wolff-Rouendaal D. (1983). HLA and ABO antigens in malignant choroidal melanonia. Clin. exp. Immunol 53: 581–588.
Wachtmeister L., Ingemansson S., and Möller E. Atopy and HLA antigens in patients with keratoconus. Acta Ophthalmol. 60: 113–122.
References
Damgaard-Jensen L., Ehlers N and Kissmeyer Nielsen F. (1979) HLA types in corneal diseases. Acta Ophthal. 57: 982–985.
Doggart J.H. (1957) Fuchs' epithelial dystrophy of the cornea. Brit J. ophthal. 41: 533–540.
Edwards J.H. (1974) HLA and disease. The detection of associations. J. Immunogenet. 1: 249.
Haldane J.B.S. (1955) The estimation and significance of the logarithm of ratio of frequencies. Am. Hum. Genet. 20: 30.
Krachmer J.H., Purcell Jr. J.J., Young C.W. and Buchner K.D. (1978) Corneal endothelial dystrophy. Arch. ophthalmol 96: 2036–2039.
Nijenhuis L.E. (1961) Blood group frequencies in the Netherlands, Curacao, Suriname and New Guinea. A study in population genetics. Thesis, University Amsterdam.
Van Rood J.J. (1979) Microlymphocytotoxicity method. In: NIAID Manual of tissue typing techniques (Ed: J. Ray) National Institute of Health (NIH) (80–545) Maryland, U.S.A.: p. 104.
Wolff-Rouendaal de D., Völker-Dieben H.J. and Kok-Van Alphen C.C. (1981). The histology of iatrogenic keratitis bullosa. Doc. Ophthalmol. 50: 357–364.
Woolf B. (1955) On estimating the relation between bloodgroups and disease. Ann. Hum. Genet. 19: 251.
References
Bertrams J., Spitznas M. and Rommelfanger M. (1978) Missing evidence for HLA antigen association with Eales' disease, chorioretinitis, central serous retinopathy and malignant choroidal melanoma. Invest. Ophthalmol. 17: 9, 918–920.
Callendar G.R, Wilder H.C., Esh J.E. (1942) Five hundred melanomas of the choroid and ciliary body followed five years or longer. American Journal Ophthal. 25: 962–967.
Davidorf F.H, Lang J.R. (1974) Small malignant melanomas of the choroid. Am. J. Ophthalmol. 78: 788–793.
Dieckhues B., Jümann G., Küchle H.J., Püttmann T. (1979) HLA Antigene bei Augenerkrankungen. Klin. Mbl. Augenheilk. 175: 681–685.
Edwards J.H. (1974) HL-A and disease. The detection of associations. J. of Immunogenetics 1: 249.
Flocks M., Gerende J.H., Zimmerman L.E. (1955) The size and shape of the choroid and ciliary body in relation to the prognosis and histologic characteristics. Trans. Am. Acad. Ophthalmol. Otolaryngol. 59: 740–758.
Hagler W.S., Jarret W.H. and Killian J.H. (1977) The use of the 32P test in the management of malignant melanoma of the choroid. Tr. Am. Acad. Ophthalmol. and Otolaryngol. 83: 49–60.
Haldane J.B.S. (1955) The estimation and significance of the logarithm of ratio of frequencies. Ann. Hum. Genet. 20: 30.
Ignatov R.K., Terentyevra L.L., Shulgina N.S. (1977) A study of antigen distribution of HLA system in melanoma of the uvea (Russian). Onkologiceskij Zurnal, 14: 289.
Jensen O.A. (1970) Malignant melanomas of the human uvea. Recent follow-up of cases in Denmark 1943–1952. Acta Ophthalmol. 48: 1113–1128.
Joycey V.C., Roger J.H., Evans D.B., Hebertson B.M. (1973) Kidney graft survival and matching for HLA and ABO antigens. Nature 246: 163.
Lamm L.U., Kissmeyer-Nielsen F., Kjerbye K.E., Mogensen B. and Petersen N.C. (1974) HLA and ABO antigens and malignant melanoma. Cancer 33: 1458–1461.
Lewis M.G. (1972) Immunology of human malignant melanoma. In: Immunological Aspects of neoplasia II. Series Haematologica V 5: p. 44–65, Munksgaard, Copenhagen.
Manschot W.A. and Van Peperzeel A. (1980) Choroidal melanoma, Enucleation or observation? A new approach. Arch Ophthalmol. 98: 71–77.
Mavligit G., Guttermann J.U., Mc Bride C. and Hersh E.M. (1974) Tumor directed immune reactivity and immuno therapy in malignant melanoma. Current status. Immunology of Cancer. Prog. Exp. Tumor Res. 19: 222–252.
McDevitt H.O and Chinnitz A. (1969) Genetic control of the antibody response: relationship between immune response and Histocompatibility (H-2) type. Science 163: 1207–1208.
Paul E.V., Parnell B.L. and Fraher M. (1962) ‘Prognosis of malignant melanomas of the choroid and ciliary body’. Int. Ophthalmological Clinics 2: 387.
Van Rood J.J. (1979) Microlymphocytotoxicity method. In: NIAID Manual of tissue typing techniques (Ed: J. Ray) National Institute of Health (NIH) (80–545) Maryland, U.S.A.: p. 104.
Svejgaard A. et al. (1974) HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens 4: 95–105.
Woolf B. (1955) On estimating the relation between blood groups and disease. Ann. Hum. Genet. 19: 251.
Zimmerman L.E., McLean J.W., Foster W.D. (1978) Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br. J. Ophthalmol. 62: 420–425.
Rights and permissions
About this article
Cite this article
Völker-Dieben, H.J.M. The effect of immunological and non-immunological factors on corneal graft survival: A single centre study. Doc Ophthalmol 57, 1–151 (1984). https://doi.org/10.1007/BF00190461
Issue Date:
DOI: https://doi.org/10.1007/BF00190461